SAKK 17/18-ORIGIN trial: Efficacy and safety from a multicenter phase II trial of gemcitabine and atezolizumab in patients with advanced NSCLC progressing on immune checkpoint inhibitors

被引：0
|
作者：
Curioni-Fontecedro, A. [1 ]
Holer, L. [2 ]
Frueh, M. [3 ]
Weindler, S. [4 ]
Konig, D. [5 ]
Addeo, A. [6 ]
Britschgi, C. [7 ]
Rigutto, A. [8 ,9 ]
Waibel, C. [10 ]
Bettini, A. [11 ]
Cerciello, F. W. F. [12 ]
Hiltbrunner, S. [9 ,13 ]
Nguyen, D. L. [14 ]
Zellweger, C. [15 ]
Musilova, J. [16 ]
Von Moos, R. A. F. [17 ]
Joerger, M. [18 ]
机构：
[1] Univ Zurich Hosp, Dept Oncol, Cantonal Hosp Fribourg, Fribourg, Switzerland
[2] SAKK Swiss Grp Clin Canc Res, Bern, Switzerland
[3] Kantonsspital St Gallen, Dept Oncol, St Gallen, Switzerland
[4] Kantonsspital St Gallen, Dept Med Oncol, St Gallen, Switzerland
[5] Univ Basel Hosp, Dept Med Oncol, Basel, Switzerland
[6] HUG Hop Univ Geneve, Dept Oncol, Geneva, Switzerland
[7] USZ Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[8] Univ Zurich, Fac Sci & Med, Dept Med Surg Specialties, Zurich, Switzerland
[9] Univ Fribourg, Fribourg, Switzerland
[10] Kantonsspital Baden, Med Oncol, Baden, Switzerland
[11] HFR Hop Cantonal, Med Oncol, Fribourg, Switzerland
[12] Univ Klin Med Onkol, Dept Med Oncol, Inselspital, Bern, Switzerland
[13] Univ Zurich Hosp, Fac Sci & Med, Zurich, Switzerland
[14] Stadtsp Zurich Triemli, Dept Radiol & Nucl Med, Zurich, Switzerland
[15] USZ Univ Hosp Zurich, Dept Radiol, Inst Diagnost & Intervent Radiol, Zurich, Switzerland
[16] SAKK Swiss Grp Clin Canc Res, Dept Stat, Bern, Switzerland
[17] KSGR Kantonsspital Graubunden, Dept Hematol Oncol, Chur, Switzerland
[18] Kantonsspital St Gallen, Med Oncol & Hematol Dept, St Gallen, Switzerland
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2444
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1412P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SAKK 17/16-Lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma: A multicenter, single-arm phase II trial
    Metaxas, Y.
    Xyrafas, A.
    Mark, M. T.
    Pless, M.
    Frueh, M.
    Froesch, P. R.
    Schneider, M.
    Rudolf, C. Biaggi
    Grosso, F.
    von Moos, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 644 - 644
  • [32] Efficacy and safety of FOLFIRINOX in advanced biliary tract cancer after failure of gemcitabine plus cisplatin: A phase II trial.
    Belkouz, Ali
    de Vos-Geelen, Judith
    Eskens, Ferry
    Mathot, Ron A. A.
    van Gulik, Thomas
    van Oijen, Martijn G. H.
    Punt, Cornelis J. A.
    Wilmink, Johanna
    Kluempen, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial
    Pacey, Simon
    Ratain, Mark J.
    Flaherty, Keith T.
    Kaye, Stanley B.
    Cupit, Lisa
    Rowinsky, Eric K.
    Xia, Chenghua
    O'Dwyer, Peter J.
    Judson, I. R.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (03) : 481 - 488
  • [34] Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial
    Simon Pacey
    Mark J. Ratain
    Keith T. Flaherty
    Stanley B. Kaye
    Lisa Cupit
    Eric K. Rowinsky
    Chenghua Xia
    Peter J. O’Dwyer
    I. R. Judson
    Investigational New Drugs, 2011, 29 : 481 - 488
  • [35] Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
    Sheng, Xinan
    Chen, Haige
    Hu, Bin
    Yao, Xudong
    Liu, Ziling
    Yao, Xin
    Guo, Hongqian
    Hu, Yi
    Ji, Zhigang
    Luo, Hong
    Shi, Benkang
    Liu, Jiyan
    Wu, Jin
    Zhou, FangJian
    He, Zhisong
    Fan, Jinhai
    Wang, Weifeng
    Feng, Hui
    Yao, Sheng
    Keegan, Patricia
    Huang, Yiran
    Guo, Jun
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 489 - 497
  • [36] Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer:: a multicenter phase II trial
    Boeck, S.
    Weigang-Koehler, K.
    Fuchs, M.
    Kettner, E.
    Quietzsch, D.
    Trojan, J.
    Stoetzer, O.
    Zeuzem, S.
    Lordick, F.
    Koehne, C. -H.
    Kroening, H.
    Steinmetz, T.
    Depenbrock, H.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2007, 18 (04) : 745 - 751
  • [37] Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial
    Chen, Yunfei
    Xu, Yanmei
    Huang, Yueting
    Sun, Ting
    Hu, Yuefen
    Xue, Feng
    Peng, Xuanwei
    Lai, Yinghui
    Zhou, Zeping
    Zhou, Hu
    Zhou, Rongfu
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Ju, Mankai
    Dai, Xinyue
    Li, Huiyuan
    Liu, Xiaonan
    Ma, Yueshen
    Song, Zhen
    Peng, Jun
    Yang, Renchi
    Zhang, Lei
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) : E22 - E25
  • [38] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, P
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, A
    LUNG CANCER, 2005, 49 : S34 - S34
  • [39] A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
    Ichida, Akihiko
    Arita, Junichi
    Hatano, Etsuro
    Eguchi, Susumu
    Saiura, Akio
    Nagano, Hiroaki
    Shindoh, Junichi
    Hashimoto, Masaji
    Takemura, Nobuyuki
    Taura, Kojiro
    Sakamoto, Yoshihiro
    Takahashi, Yu
    Seyama, Yasuji
    Sasaki, Yasuharu
    Uemura, Kohei
    Kokudo, Norihiro
    Hasegawa, Kiyoshi
    LIVER CANCER, 2024, 13 (03) : 322 - 334
  • [40] Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
    Petersenn, S.
    Schopohl, J.
    Barkan, A.
    Mohideen, P.
    Colao, A.
    Abs, R.
    Buchelt, A.
    Ho, Y. -Y.
    Hu, K.
    Farrall, A. J.
    Melmed, S.
    Biller, B. M. K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06): : 2781 - 2789
12345